Taiko Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3442200006
JPY
302.00
5 (1.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
2,168.00
1,817.00
1,262.00
1,150.00
1,713.00
1,719.00
1,483.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,168.00
1,817.00
1,262.00
1,150.00
1,713.00
1,719.00
1,483.00
Raw Material Cost
1,048.00
777.00
620.00
471.00
762.00
683.00
603.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.00
1.00
2.00
1.00
2.00
2.00
2.00
Selling and Distribution Expenses
986.00
763.00
639.00
634.00
1,048.00
792.00
576.00
Other Expenses
-0.10
-0.10
-0.20
-0.10
-0.20
-0.20
3.40
Total Expenditure (Excl Depreciation)
2,034.00
1,540.00
1,259.00
1,105.00
1,810.00
1,475.00
1,215.00
Operating Profit (PBDIT) excl Other Income
134
277
3
45
-97
244
268
Other Income
23.00
14.00
7.00
316.00
91.00
-66.00
35.00
Operating Profit (PBDIT)
229.00
359.00
75.00
421.00
60.00
240.00
368.00
Interest
1.00
1.00
2.00
1.00
2.00
2.00
2.00
Exceptional Items
-20.00
151.00
4.00
10.00
-99.00
-228.00
-4.00
Gross Profit (PBDT)
1,120.00
1,040.00
642.00
679.00
951.00
1,036.00
880.00
Depreciation
72.00
68.00
65.00
60.00
66.00
62.00
65.00
Profit Before Tax
137.00
439.00
14.00
368.00
-108.00
-51.00
295.00
Tax
-117.00
49.00
26.00
76.00
-291.00
-1.00
2.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
254.00
390.00
-13.00
292.00
184.00
-50.00
292.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
254.00
390.00
-13.00
292.00
184.00
-50.00
292.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
254.00
390.00
-13.00
292.00
184.00
-50.00
292.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
8,518.00
8,236.00
7,948.00
7,979.00
7,964.00
8,064.00
8,074.00
Earnings per share (EPS)
5.05
7.76
-0.26
5.82
3.67
-1.0
5.82
Diluted Earnings per share
5.05
7.76
-0.26
5.82
3.67
-1.0
5.82
Operating Profit Margin (Excl OI)
6.18%
15.24%
0.24%
3.91%
-5.66%
14.19%
18.07%
Gross Profit Margin
9.64%
27.9%
6.26%
37.22%
-2.45%
0.64%
24.28%
PAT Margin
11.72%
21.46%
-1.03%
25.39%
10.74%
-2.91%
19.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 19.32% vs 43.98% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -34.87% vs 3,100.00% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -40.29% vs 407.35% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Taiko Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
2,168.00
17,036.00
-14,868.00
-87.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,168.00
17,036.00
-14,868.00
-87.27%
Raw Material Cost
1,048.00
12,617.00
-11,569.00
-91.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.00
80.00
-79.00
-98.75%
Selling and Distribution Expenses
986.00
3,297.00
-2,311.00
-70.09%
Other Expenses
-0.10
-8.00
7.90
98.75%
Total Expenditure (Excl Depreciation)
2,034.00
15,914.00
-13,880.00
-87.22%
Operating Profit (PBDIT) excl Other Income
134.00
1,122.00
-988.00
-88.06%
Other Income
23.00
163.00
-140.00
-85.89%
Operating Profit (PBDIT)
229.00
1,953.00
-1,724.00
-88.27%
Interest
1.00
80.00
-79.00
-98.75%
Exceptional Items
-20.00
0.00
-20.00
Gross Profit (PBDT)
1,120.00
4,419.00
-3,299.00
-74.65%
Depreciation
72.00
668.00
-596.00
-89.22%
Profit Before Tax
137.00
1,204.00
-1,067.00
-88.62%
Tax
-117.00
351.00
-468.00
-133.33%
Provisions and contingencies
0
0
0.00
Profit After Tax
254.00
853.00
-599.00
-70.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
254.00
853.00
-599.00
-70.22%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
254.00
853.00
-599.00
-70.22%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
8,518.00
34,655.00
-26,137.00
-75.42%
Earnings per share (EPS)
5.05
99.91
-94.86
-94.95%
Diluted Earnings per share
5.05
99.91
-94.86
-94.95%
Operating Profit Margin (Excl OI)
6.18%
6.59%
0.00
-0.41%
Gross Profit Margin
9.64%
10.99%
0.00
-1.35%
PAT Margin
11.72%
5.01%
0.00
6.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 216.80 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 19.32% vs 43.98% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 26.56% vs 0.59% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 25.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -34.87% vs 3,100.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 38.04% vs 106.03% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -40.29% vs 407.35% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 764.52% vs 91.95% in Dec 2024

Quarterly - Interest
Interest 0.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -50.00% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.18%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024